Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin as Add-on Therapy in Refractory Chronic Rhinosinusitis
NCT02307825Phase 4Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Nov 2014
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in chronic rhinosinusitis (CRS), sponsored by Centre hospitalier de l’Université de Montréal. Started Nov 2014; status: completed.
02
Drugs
azithromycin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT02307825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02307825.